Teladoc Health, Inc. (NYSE:TDOC) Expected to Announce Earnings of -$0.71 Per Share

Wall Street brokerages expect Teladoc Health, Inc. (NYSE:TDOCGet Rating) to post earnings per share of ($0.71) for the current quarter, according to Zacks Investment Research. Nine analysts have issued estimates for Teladoc Health’s earnings. The highest EPS estimate is ($0.61) and the lowest is ($1.13). Teladoc Health reported earnings of ($0.86) per share in the same quarter last year, which indicates a positive year-over-year growth rate of 17.4%. The firm is scheduled to announce its next quarterly earnings report on Monday, January 1st.

According to Zacks, analysts expect that Teladoc Health will report full year earnings of ($43.18) per share for the current year, with EPS estimates ranging from ($44.16) to ($42.69). For the next year, analysts expect that the company will post earnings of ($1.60) per share, with EPS estimates ranging from ($3.16) to ($0.48). Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that follow Teladoc Health.

Teladoc Health (NYSE:TDOCGet Rating) last released its earnings results on Wednesday, April 27th. The health services provider reported ($41.58) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.58) by ($41.00). Teladoc Health had a negative return on equity of 2.12% and a negative net margin of 321.94%. During the same period last year, the company earned $0.13 earnings per share.

Several research firms have issued reports on TDOC. Deutsche Bank Aktiengesellschaft dropped their price target on Teladoc Health from $78.00 to $44.00 in a report on Thursday, April 28th. Barclays cut their target price on shares of Teladoc Health from $77.00 to $45.00 in a research note on Thursday, April 28th. StockNews.com assumed coverage on shares of Teladoc Health in a research note on Thursday, March 31st. They set a “sell” rating on the stock. UBS Group cut their target price on shares of Teladoc Health from $130.00 to $72.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 8th. Finally, Robert W. Baird cut their target price on shares of Teladoc Health from $72.00 to $64.00 in a research note on Wednesday, April 27th. One analyst has rated the stock with a sell rating, nineteen have assigned a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $90.68.

In related news, SVP Andrew Turitz sold 1,754 shares of the stock in a transaction dated Thursday, March 3rd. The shares were sold at an average price of $70.24, for a total value of $123,200.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Mala Murthy sold 6,717 shares of the stock in a transaction dated Thursday, March 3rd. The stock was sold at an average price of $70.24, for a total transaction of $471,802.08. The disclosure for this sale can be found here. Insiders have sold 14,842 shares of company stock valued at $1,042,502 in the last ninety days. 1.55% of the stock is owned by company insiders.

A number of large investors have recently bought and sold shares of TDOC. Altshuler Shaham Ltd increased its holdings in shares of Teladoc Health by 15.4% during the third quarter. Altshuler Shaham Ltd now owns 750 shares of the health services provider’s stock worth $95,000 after buying an additional 100 shares in the last quarter. First Mercantile Trust Co. increased its holdings in shares of Teladoc Health by 1.1% during the third quarter. First Mercantile Trust Co. now owns 9,550 shares of the health services provider’s stock worth $1,211,000 after buying an additional 100 shares in the last quarter. Personal CFO Solutions LLC grew its stake in shares of Teladoc Health by 4.5% during the third quarter. Personal CFO Solutions LLC now owns 2,531 shares of the health services provider’s stock valued at $321,000 after purchasing an additional 110 shares during the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of Teladoc Health by 5.2% during the fourth quarter. The Manufacturers Life Insurance Company now owns 2,766 shares of the health services provider’s stock valued at $254,000 after purchasing an additional 137 shares during the last quarter. Finally, Benjamin Edwards Inc. grew its stake in shares of Teladoc Health by 27.6% during the fourth quarter. Benjamin Edwards Inc. now owns 670 shares of the health services provider’s stock valued at $62,000 after purchasing an additional 145 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Shares of NYSE TDOC traded down $0.17 during trading on Friday, hitting $32.74. The company had a trading volume of 5,053,111 shares, compared to its average volume of 15,402,974. The company has a market cap of $5.28 billion, a P/E ratio of -0.76 and a beta of 0.82. Teladoc Health has a 52 week low of $27.38 and a 52 week high of $174.32. The business’s 50-day moving average is $55.02 and its 200 day moving average is $77.14. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.71 and a current ratio of 3.94.

Teladoc Health Company Profile (Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Featured Articles

Get a free copy of the Zacks research report on Teladoc Health (TDOC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.